Larimar Therapeutics, Inc. (NasdaqGM: LRMR)
Health Care · Biotechnology · US
$4.13
+1.85% today · +8.9% 1Y
Larimar Therapeutics, Inc. (NasdaqGM: LRMR) operates in the Biotechnology industry within the Health Care sector. The company is valued at $422.75M and employs 71 people.
Over the last twelve months the share price has gained 8.9%, trading between 2.72 and 6.42.
Tweenvest scores Larimar Therapeutics, Inc. across four factors: quality 27/100. Its strongest factor is quality.
LRMR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $422.75M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.93
- Dividend yield
- —
- Beta (5Y)
- 0.75
- 52-week high
- $6.42
- 52-week low
- $2.72
- Avg volume (3M)
- —
- Shares outstanding
- 104.38M
- Employees
- 71
- Next earnings
- —
About Larimar Therapeutics, Inc.
Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a distinctive cell-penetrating peptide technology platform. The company's foremost experimental therapy, CTI-1601, is presently undergoing Phase 1 clinical trials. This drug candidate is being developed to combat Friedreich's ataxia, a genetic illness that is rare, relentlessly progressive, and ultimately fatal.
- ISIN
- US5171251003
- Listed since
- Jun 19, 2014
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $266.29 | +0.67% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $445.02 | +0.27% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $148.42 | +1.14% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $555.26 | +1.40% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $837.90 | +1.13% |
| argenx SEENXTBR: ARGX | $63.06B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $157.60 | +13.47% |
Figures last refreshed Aug 18, 2026.